In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya

1989 ◽  
Vol 24 (suppl A) ◽  
pp. 183-186 ◽  
Author(s):  
L. Slaney ◽  
H. Chubb ◽  
Z. Mohammed ◽  
A. Ronald
1987 ◽  
Vol 63 (3) ◽  
pp. 215-216
Author(s):  
M C Lozano ◽  
J C Palomares ◽  
R Prados ◽  
E J Perea

2010 ◽  
Vol 54 (9) ◽  
pp. 3970-3973 ◽  
Author(s):  
Kozue Kishii ◽  
Naoko Chiba ◽  
Miyuki Morozumi ◽  
Akiko Ono ◽  
Takashi Ida ◽  
...  

ABSTRACT In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was compared with those of 8 reference agents. Isolates were classified into 6 resistance classes after PCR identification of β-lactamase genes and ftsI gene mutations. For all isolates, the minimal concentration at which 90% of isolates were inhibited was lower for tebipenem than for the reference oral antibiotics, except for cefditoren. Tebipenem also showed excellent bactericidal activity against β-lactamase-nonproducing, ampicillin-resistant isolates.


1995 ◽  
Vol 39 (4) ◽  
pp. 987-989 ◽  
Author(s):  
J S Knapp ◽  
S W Neal ◽  
M C Parekh ◽  
R J Rice

The susceptibilities of 216 strains of Neisseria gonorrhoeae to a new fluoroquinolone, CP-99,219 were determined. For strains for which the MICs of ciprofloxacin were < or = 0.06 microgram/ml, the MICs at which 90% of the isolates are inhibited (MIC90s) of CP-99,219, ciprofloxacin, and ofloxacin were 0.008, 0.015, and 0.03 microgram/ml, respectively. For strains for which the MICs of ciprofloxacin were 0.125 to 0.5 microgram/ml, the MIC90s of CP-99,219, ciprofloxacin, and ofloxacin were 0.06, 0.25, and 0.5 microgram/ml, respectively. For strains for which the MICs of ciprofloxacin and ofloxacin were 2.0 micrograms/ml, the MIC of CP-99,219 was 0.25 microgram/ml.


1983 ◽  
Vol 23 (3) ◽  
pp. 481-482 ◽  
Author(s):  
M Y Khan ◽  
R P Gruninger ◽  
S M Nelson ◽  
M L Simpson

Sign in / Sign up

Export Citation Format

Share Document